NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors

被引：0
作者：
Chang, Michael S. [1 ,2 ]
Said, Jordan T. [1 ,2 ]
Akama-Garren, Elliot H. [1 ,2 ]
Trepanowski, Nicole [2 ,3 ]
Bui, Ai-Tram N. [1 ,2 ]
Giobbie-Hurder, Anita [4 ]
Leboeuf, Nicole R. [1 ,2 ,5 ]
Hartman, Rebecca I. [1 ,2 ,6 ]
机构：
[1] Harvard Med Sch, BOSTON, MA USA
[2] Brigham & Womens Hosp, Dept Dermatol, 221 Longwood Ave, Boston, MA 02215 USA
[3] Boston Univ, Sch Med, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Data Sci, Div Biostat, Boston, MA USA
[5] Dana Farber Brigham & Womens Canc Ctr, Ctr Cutaneous Oncol, Boston, MA USA
[6] Vet Integrated Serv Network VISN 1, Dept Dermatol, Jamaica Plain, MA USA
来源：
JAAD INTERNATIONAL | 2025年 / 18卷
基金：
美国国家卫生研究院;
关键词：
anti-PDL-1; atezolizumab; avelumab; cemiplimab; dAE; durvalumab; ICI; ipilimumab; melanoma; mutation; nivolumab; NRAS; pembrolizumab;
D O I：
10.1016/j.jdin.2024.11.004
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：165 / 167
页数：3
相关论文
共 50 条
  • [21] Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
    Tyan, Kevin
    Baginska, Joanna
    Brainard, Martha
    Giobbie-Hurder, Anita
    Severgnini, Mariano
    Manos, Michael
    Haq, Rizwan
    Buchbinder, Elizabeth I.
    Ott, Patrick A.
    Hodi, F. Stephen
    Rahma, Osama E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2209 - 2221
  • [22] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [23] Cutaneous adverse events associated with immune checkpoint inhibitors
    Graen, Franziska
    Schilling, Bastian
    AKTUELLE DERMATOLOGIE, 2023, 49 (11) : 517 - 524
  • [24] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [25] Pancreatic adverse events in patients treated with immune checkpoint inhibitors
    Hana, Caroline
    Rehman, Tauseef
    Park, Kyeeun
    Uribe, Carlos Carracedo
    Aung, Pyi Phyo
    Hunis, Brian
    Salzberg, Matthew
    Zikria, Jennifer
    Hussein, Atif
    JGH OPEN, 2023, 7 (03): : 204 - 207
  • [26] Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors
    Graen, Franziska
    Schilling, Bastian
    AKTUELLE RHEUMATOLOGIE, 2022, 47 (04) : 344 - 352
  • [27] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
  • [28] Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies
    Noble, Carl W.
    Gangaputra, Sapna S.
    Thompson, Ian A.
    Yuan, Amy
    Apolo, Andrea B.
    Lee, Jung-Min
    Papaliodis, George N.
    Kodati, Shilpa
    Bishop, Rachel
    Magone, M. Teresa
    Sobrin, Lucia
    Sen, H. Nida
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (06) : 854 - 859
  • [29] Posterior cord syndrome associated with immune checkpoint inhibitors for metastatic melanoma
    Secco, L. -p.
    Lesage, C.
    Lippi, A.
    Maria, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (03): : 193 - 194
  • [30] Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
    Chen, Chieh-Hsun
    Yu, Hsin-Su
    Yu, Sebastian
    CURRENT ONCOLOGY, 2022, 29 (04) : 2871 - 2886
12345